Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients' Perceptions and Experience towards Root Canal Treatment: A Prospective Analytical Study.

Kathmandu University medical journal (KUMJ)·2026
Same author

Cone-Beam Computed Tomographic Study of the Internal Anatomy of Lower Anterior Teeth.

Kathmandu University medical journal (KUMJ)·2024
See all related articles

Related Experiment Video

Updated: Jul 12, 2026

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

Takotsubo disease.

M Nepal1

  • 1Mercy Catholic Medical Center, Drexel Univ, Philadelphia, PA, 19023, USA. manojnepal@gmail.com

JNMA; Journal of the Nepal Medical Association
|August 28, 2007
PubMed
Summary

Tako-tsubo cardiomyopathy, a reversible heart condition, presents as left ventricular dysfunction, often in elderly women. It mimics heart attacks but lacks coronary blockages, with most patients fully recovering.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Tako-tsubo cardiomyopathy (TTC) is a heart syndrome with unique left ventricular dysfunction.
  • It features apical akinesis and basal hyperkinesis, often in older, stressed females without obstructive coronary artery disease.
  • Initially described in Japan, TTC is now recognized in Western populations.

Purpose of the Study:

  • To review the characteristics, pathophysiology, and clinical presentation of Tako-tsubo cardiomyopathy.
  • To highlight diagnostic challenges and management considerations for this condition.

Main Methods:

  • Review of existing literature on Tako-tsubo cardiomyopathy.
  • Analysis of clinical presentations, diagnostic criteria, and proposed pathophysiological mechanisms.

More Related Videos

Ultrasonic Assessment of Myocardial Microstructure
10:53

Ultrasonic Assessment of Myocardial Microstructure

Published on: January 14, 2014

Related Experiment Videos

Last Updated: Jul 12, 2026

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

Ultrasonic Assessment of Myocardial Microstructure
10:53

Ultrasonic Assessment of Myocardial Microstructure

Published on: January 14, 2014

Main Results:

  • TTC is characterized by transient, reversible left ventricular dysfunction.
  • Coronary angiography typically reveals no critical obstructive lesions, differentiating it from myocardial infarction.
  • Potential mechanisms include multivessel coronary spasm and catecholamine hypersensitivity.

Conclusions:

  • Tako-tsubo cardiomyopathy presents similarly to acute myocardial infarction but has a distinct pathophysiology.
  • Early recognition is crucial, even in the absence of traditional risk factors, to guide appropriate management.
  • While generally benign with full recovery, TTC can occasionally be fatal.